Congress Speakers 2019


The LSX World Congress USA is a CxO level conference and attracts high-quality speakers from investors, biotechs and pharma creating an agenda to educate investors and corporates on the most exciting new technology and therapeutic areas in healthcare today.

Laurent Audoly, President & CEO, Kymera Therapeutics

Laurent Audoly
President & CEO, Kymera Therapeutics
Kymera Therapeutics

Jake Becraft, Co-founder, CEO, Strand Therapeutics

Jake Becraft
CEO, Strand Therapeutics

Strand Therapeutics

Jeff Behrens, President & CEO, Siamab Therapeutics

Jeff Behrens
President & CEO, Siamab Therapeutics

Siamab Therapeutics

Laura Benjamin, Founder & CEO, Oncologie

Laura Benjamin
Founder & CEO, Oncologie

Oncologie

David De Graaf, CEO, Comet Therapeutics

David De Graaf
CEO, Comet Therapeutics

Comet Therapeutics

Peter Dudek, Partner, MRL Ventures Fund

Peter Dudek
Partner, MRL Ventures Fund
MRL Ventures Fund

Melissa Fensterstock, Co-Founder & CEO, Landsdowne Labs

Melissa Fensterstock
Co-Founder & CEO, Landsdowne Labs
Landsdowne Labs

Meredith Fisher, Partner, Partners Innovation Fund, Partners Healthcare

Meredith Fisher
Partner, Partners Innovation Fund, Partners Healthcare

Partners Healthcare

Todd Foley, Managing Partner, MPM Capital

Todd Foley
Managing Partner, MPM Capital
MPM Capital

John Glasspool, CEO, Anthos Therapeutics

John Glasspool
CEO, Anthos Therapeutics

Anthos Therapeutics

Kelly Gold, VP, Corporate Development, CAMP4 Therapeutics

Kelly Gold
VP, Corporate Development, CAMP4 Therapeutics
CAMP4 Therapeutics

Dan Grau, CEO, Sojournix

Dan Grau
CEO, Sojournix
Sojournix

Adam Houghton, Vice President and Head, AbbVie Ventures

Adam Houghton
VP & Head, AbbVie Ventures
AbbVie Ventures

Nouhad Husseini, VP, Head of Business Development, Regeneron Pharmaceuticals

Nouhad Husseini
VP, Head of Business Development, Regeneron Pharmaceuticals

Regeneron Pharmaceuticals 300x

Ed Kaye, CEO, Stoke Therapeutics

Ed Kaye
CEO, Stoke Therapeutics

Stoke Therapeutics 300x

Nicole Bocskocsky, VP of Clinical Operations, Parsley Health 300x

Nicole Bocskocsky
VP of Clinical Operations, Parsley Health
Parsley Health

Philippe Lopes-Fernandes, SVP, Global Head of BD & Alliance Management, Merck Serono

Philippe Lopes-Fernandes
VP, Global Head of BD & Alliance Management, Merck KGaA

Merck-1

Michael Pavia, CEO, Tuned Therapeutics

Michael Pavia
CEO, Tuned Therapeutics

Veronique Riethuisen, SVP, Global Head of Business Development & Alliance Management, Ipsen

Veronique Riethuisen
SVP, Global Head of Business Development & Alliance Management, Ipsen

Ipsen Ventures 300x

Priyanka Rohatgi, Managing Director, Head, Ipsen Ventures

Priyanka Rohatgi
Managing Director, Head, Ipsen Ventures
Ipsen Ventures

Adam Rosenberg, President & CEO, Rodin Therapeutics

Adam Rosenberg
President & CEO, Rodin Therapeutics
Rodin Therapeutics

Nigel Sheail, Global Head of Mergers & Acquisitions and Business Development & Licensing, Novarits

Nigel Sheail
Global Head of M&A & Business Development & Licensing, Novartis

Novarits 300x

Marshall Smith, Head of Global Healthcare, Goldman Sachs

Marshall Smith
Head of Global Healthcare, Goldman Sachs
Goldman Sachs

Aaron Nelson, Principal, Novartis Venture Fund

Aaron Nelson
Principal, Novartis Venture Fund

Novartis Venture Fund

Ricky Sun, Partner, Life Sciences, Bain Capital

Ricky Sun
Partner, Life Sciences, Bain Capital
Bain Capital

Ted Tanner Jr., CTO and Chief Architect, Watson Health, IBM (1)

Ted Tanner Jr.
CTO & Chief Architect, Watson Health, IBM
IBM

Rogerio Vivaldi, CEO, Sigilon Therapeutics

Rogerio Vivaldi
CEO, Sigilon Therapeutics
Sigilon Therapeutics

Alex Bargar, VP of Clinical Services, Simple Health

Alex Bargar
VP of Clinical Services, Simple Contacts
Simple Contacts 300x

Carolyn Witte, Co-Founder and CEO, Tia

Carolyn Witte
Co-Founder & CEO, Tia
Tia 300x

Beyhan Zaim, SVP, Commercial Business Development, Novo Nordisk

Beyhan Zaim
SVP, Commercial Business Development, Novo Nordisk

Novo Nordisk 300x

Alan Crane, Entrepreneur Partner, Polaris Partners

Alan Crane
Entrepreneur Partner, Polaris Partners
Polaris Partners

Joshua Resnick, Managing Partner, RA Capital Management

Joshua Resnick
Managing Partner, RA Capital Management
RA Capital Management

Christine Swenson, Head, Regulatory Affairs, Moderna Therapeutics

Christine Swenson
Regulatory Affairs, Moderna Therapeutics

Moderna Therapeutics 300x

Andrew ElBardissi, Principal, Deerfield Management

Andrew ElBardissi
Principal, Deerfield Management

Deerfield Management

Martin Driscoll, President & Chief Executive Officer, Spring Bank Pharmaceuticals

Martin Driscoll
President & CEO, Spring Bank Pharmaceuticals

Spring Bank Pharmaceuticals

Neal Farber, CEO, NeuroHealing Pharmaceuticals

Neal Farber
CEO, NeuroHealing Pharmaceuticals

NeuroHealing Pharmaceuticals

Ailis Tweed-Kent, CEO, Cocoon Biotech

Ailis Tweed-Kent
CEO, Cocoon Biotech

Cocoon Biotech

Alexandra Glücksmann, CEO, Cedilla Therapeutics

Alexandra Glücksmann
CEO, Cedilla Therapeutics

Cedilla Therapeutics

Kenneth Barr, SVP, Head of Discovery Services, Syngene

Kenneth Barr
SVP, Head of Discovery Services, Syngene

Syngene 300x

Satish Sanan, Chairman and CEO, Inspirata

Satish Sanan
Chairman and CEO, Inspirata, Inc.

Inspirata

Deanna Petersen, CBO, AvroBio

Deanna Petersen
CBO, AvroBio

AvroBio 300x

Laurie Smaldone Alsup, MD, CSO, NDA Group

Laurie Smaldone Alsup
MD, CSO, NDA Group

NDA Group 300x

Constantine Chinoporos, CBO, Boston Pharmaceuticals

Constantine Chinoporos
CBO, Boston Pharmaceuticals

Boston Pharmaceuticals

Derek Stoldt, Co-head, M&A & Life Sciences Transactions Practice, Arnold & Porter

Derek Stoldt
Co-head, M&A & Life Sciences Transactions Practice, Arnold & Porter

Arnold & Porter 300x

Ori Solomon, Partner, Corporate Department & Co-chair, Emerging Companies & Venture Capital, Morrison Foerster

Ori Solomon
Partner, Corporate Department & Co-chair, Emerging Companies & Venture Capital, Morrison Foerster

Morrison Foerster 300x

John Hodgson

John Hodgson
Director, PersComm Ltd.

Donna LaVoie, President & CEO, LaVoie Health Science 300x

Donna LaVoie
President & CEO, LaVoie Health Science

LaVoie Health Science

Laura Tadvalkar, Principal, MP Healthcare Venture Management

Laura Tadvalkar
Principal, MP Healthcare Venture Management

MP Healthcare Venture Management 300x

Aradhana Sarin, Chief Strategy & Business Officer, Alexion Pharmaceuticals

Aradhana Sarin
Chief Strategy & Business Officer, Alexion Pharmaceuticals

Alexion Pharmaceuticals

Patrick Jordan, CEO, Mycovia

Patrick Jordan
CEO, Mycovia

Mycovia

Anne Whitaker, CEO & Director, Dance Biopharm

Anne Whitaker
CEO & Director, Dance Biopharm

Dance Biopharm 300x

Christopher Stepanian, CEO, WindGap Medical

Christopher Stepanian
CEO, WindGap Medical

WindGap Medical 300x

Mark R. Fitzgerald, Partner, Wilson Sonsini Goodrich & Rosati 300x

Mark R. Fitzgerald
Partner, Wilson Sonsini Goodrich & Rosati

Wilson Sonsini

James Sietstra, CBO & Co-Founder, Totient, Inc.

James Sietstra
CBO & Co-Founder, Totient, Inc.

Totient

Sharon Choe, SVP, IR & Business Development, LaVoie Health Science

Sharon Choe
SVP, IR & Business Development, LaVoie Health Science

LaVoie Health Science 300x

Jay Margolis, VP & GM, Strategy & Portfolio Planning, IQVIA

Jay Margolis
VP & GM, Strategy & Portfolio Planning, IQVIA

IQVIA 300x-1

Thomas Goodin, Senior Director, Clinical Development, Sunovion Pharmaceuticals Inc.

Thomas Goodin
Senior Director, Clinical Development, Sunovion Pharmaceuticals Inc.

Sunovion Pharmaceuticals 300x

Darin DeCarlo, Sr Principal & Segment Lead, IQVIA

Darin DeCarlo
Sr Principal & Segment Lead, IQVIA

IQVIA 300x-1

DOWNLOAD THE BROCHURE